美邦股份 (605033.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

30.3x

Market Cap

CNY 2.60B

MomentumView details →

1D Return

+1.85%

YTD Return

−0.50%

RSI (14)

55.9

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

30.3x

Market Cap

CNY 2.60B

RSI (14)

55.9

MomentumView details →

1D Return

+1.85%

YTD Return

−0.50%

ProfitabilityView details →

Gross Margin

35.34%

Net Margin

5.67%

EBITDA Margin

8.83%

ROE (TTM)

4.57%

ROA (TTM)

2.76%

Asset Turnover

0.47x

GrowthView details →

Revenue YoY

+11.13%

EPS YoY

+142.69%

FCF YoY

−42.51%

Revenue CAGR 3Y

+0.22%

EPS CAGR 3Y

−30.45%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.13x

Current Ratio

2.39x

Quick Ratio

2.02x

Div Yield

0.75%

Div Rate

CNY 0.15

Div Growth 1Y

−33.33%

Financials snapshotView financials →

Revenue (TTM)

958.88M

Net Income (TTM)

54.33M

Op. CF (TTM)

190.50M

Latest newsMore news →

Meibang Co. announced it will use 1 million US dollars of its own funds to establish a wholly-owned subsidiary Meibang Pharmaceutical (Hong Kong) Co., Ltd. in Hong Kong, with a registered capital of 500,000 Hong Kong dollars.10h ago

Meibang Co. announced it will inject 80 million yuan of its own funds into its wholly-owned subsidiary Shaanxi Nuozheng Biotechnology Co., Ltd., increasing the subsidiary's registered capital from 100 million yuan to 180 million yuan, with Meibang's 100% stake unchanged.10h ago

Similar companies

大湖股份600257.SH Hyperliquid Strategies Inc Common StockPURR 先达股份603086.SH 六国化工600470.SH 中农立华603970.SH N2OFF, Inc.NITO Find similar companies →

Latest newsMore news →

Meibang Co. announced it will use 1 million US dollars of its own funds to establish a wholly-owned subsidiary Meibang Pharmaceutical (Hong Kong) Co., Ltd. in Hong Kong, with a registered capital of 500,000 Hong Kong dollars.10h ago Meibang Co. announced it will inject 80 million yuan of its own funds into its wholly-owned subsidiary Shaanxi Nuozheng Biotechnology Co., Ltd., increasing the subsidiary's registered capital from 100 million yuan to 180 million yuan, with Meibang's 100% stake unchanged.10h ago